Clinical Focus ›› 2026, Vol. 41 ›› Issue (1): 84-90.doi: 10.3969/j.issn.1004-583X.2026.01.015
• Original article • Previous Articles Next Articles
-
Received:2025-10-15Online:2026-01-20Published:2026-02-02
CLC Number:
Cite this article
share this article
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.lchc.cn/EN/10.3969/j.issn.1004-583X.2026.01.015
| [1] | Thawkar B, Rizwani F, Jain K. Drug-induced acute kidney injury: Mechanisms, biomarkers, and therapeutic strategies[J]. Curr Drug Saf, 2025. doi: 10.2174/0115748863362596250627155607. |
| [2] | Huang YZ, Chen YM, Lin CC, et al. A nursing note-aware deep neural network for predicting mortality risk after hospital discharge[J]. Int J Nurs Stud, 2024, 156:104797. doi: 10.1016/j.ijnurstu.2024.104797. |
| [3] | Nimri R, Phillip M. Enhancing care in type 1 diabetes with artificial intelligence driven clinical decision support systems[J]. Horm Res Paediatr, 2025, 98(4):384-395. doi: 10.1159/000546713. |
| [4] | Saeed I, Hashmi MU, Khalid M, et al. The role of artificial intelligence in heart failure diagnostics, risk prediction, and therapeutic strategies: A comprehensive review[J]. Cureus, 2025, 17(7):e87130. doi: 10.7759/cureus.87130. |
| [5] | Nakai K, Umehara M, Minamida A, et al. Streptozotocin induces renal proximal tubular injury through p53 signaling activation[J]. Sci Rep, 2023, 13(1):8705. doi: 10.1038/s41598-023-35850-w. |
| [6] | Okamoto K, Saito Y, Narumi K, et al. Comparison of the nephroprotective effects of non-steroidal anti-inflammatory drugs on cisplatin-induced nephrotoxicity in vitro and in vivo[J]. Eur J Pharmacol, 2020, 884:173339. doi: 10.1016/j.ejphar.2020.173339. |
| [7] | Huo X, Meng Q, Wang C, et al. Protective effect of cilastatin against diclofenac-induced nephrotoxicity through interaction with diclofenac acyl glucuronide via organic anion transporters[J]. Br J Pharmacol, 2020, 177(9):1933-1948. doi: 10.1111/bph.14957. |
| [8] | He Y, Peng E, Ba X, et al. Ros responsive cerium oxide biomimetic nanoparticles alleviates calcium oxalate crystals induced kidney injury via suppressing oxidative stress and m1 macrophage polarization[J]. Small, 2025, 21(3):e2405417. doi: 10.1002/smll.202405417. |
| [9] | Wang Y, Liu Z, Ma J, et al. Lycopene attenuates the inflammation and apoptosis in aristolochic acid nephropathy by targeting the Nrf2 antioxidant system[J]. Redox Biol, 2022, 57:102494. doi: 10.1016/j.redox.2022.102494. |
| [10] | Chen W, Zhang K, Cui H, et al. Baicalin-2-ethoxyethyl ester alleviates gentamicin-induced acute kidney injury via NF-κB signaling pathway[J]. Biomed Pharmacother, 2024, 172:116276. doi: 10.1016/j.biopha.2024.116276. |
| [11] | Pavitrakar VN, Mody R, Ravindran S. Protective effects of recombinant human golimumab and pentoxifylline in nephrotoxicity induced by cisplatin[J]. J Biochem Mol Toxicol, 2022, 36(4):e22990. doi: 10.1002/jbt.22990. |
| [12] | Hasan IH, Shaheen SY, Alhusaini AM, et al. Simvastatin mitigates diabetic nephropathy by upregulating farnesoid X receptor and Nrf2/HO-1 signaling and attenuating oxidative stress and inflammation in rats[J]. Life Sci, 2024, 340:122445. doi: 10.1016/j.lfs.2024.122445. |
| [13] | Padala SA, Medepalli VM, Mohammed A, et al. Hydralazine-induced dual antineutrophil cytoplasmic antibody positive vasculitis and nephritis[J]. Cureus, 2020, 12(6):e8911. doi: 10.7759/cureus.8911. |
| [14] | Laamech R, Terrec F, Emprou C, et al. Efficacy of plasmapheresis in nivolumab-associated anca glomerulonephritis: A case report and pathophysiology discussion[J]. Case Rep Nephrol Dial, 2021, 11(3):376-383. doi: 10.1159/000518304. |
| [15] | Chen A, Yin L, Lee K, et al. Similarities and differences between covid-19-associated nephropathy and hiv-associated nephropathy[J]. Kidney Dis (Basel), 2022, 8(1):1-12. doi: 10.1159/000520235. |
| [16] | Neumann K, Tiegs G. Immune regulation in renal inflammation[J]. Cell Tissue Res, 2021, 385(2):305-322. doi: 10.1007/s00441-020-03351-1. |
| [17] | Sung C, Hayase N, Yuen P, et al. Macrophage depletion protects against cisplatin-induced ototoxicity and nephrotoxicity[J]. Sci Adv, 2024, 10(30):eadk9878. doi: 10.1126/sciadv.adk9878. |
| [18] | Sung CYW, Hayase N, Yuen PST, et al. Macrophage depletion protects against cisplatin-induced ototoxicity and nephrotoxicity[J]. bioRxiv [Preprint], 2023:2023.11.16.567274. doi: 10.1101/2023.11.16.567274. |
| [19] | Gai Z, Gui T, Kullak-Ublick GA, et al. The role of mitochondria in drug-induced kidney injury[J]. Front Physiol, 2020, 11:1079. doi: 10.3389/fphys.2020.01079. |
| [20] | Ba X, Ye T, He Y, et al. Engineered macrophage membrane-coated nanoparticles attenuate calcium oxalate nephrocalcinosis-induced kidney injury by reducing oxidative stress and pyroptosis[J]. Acta Biomater, 2025, 195:479-495. doi: 10.1016/j.actbio.2025.02.021. |
| [21] | Radi ZA. Kidney transporters and drug-induced injury in drug development[J]. Toxicol Pathol, 2020, 48(6):721-724. doi: 10.1177/0192623320937012. |
| [22] | Kulkarni P. Prediction of drug-induced kidney injury in drug discovery[J]. Drug Metab Rev, 2021, 53(2):234-244. doi: 10.1080/03602532.2021.1922436. |
| [23] | Niitsu T, Hayashi T, Uchida J, et al. Drug-induced kidney injury caused by osimertinib: Report of a rare case[J]. Nephron, 2022, 146(1):58-63. doi: 10.1159/000518774. |
| [24] | Liu C, Yan S, Wang Y, et al. Drug-induced hospital-acquired acute kidney injury in China: A multicenter cross-sectional survey[J]. Kidney Dis (Basel), 2021, 7(2):143-155. doi: 10.1159/000510455. |
| [25] | Rey A, Gras-Champel V, Choukroun G, et al. Risk factors for and characteristics of community-and hospital-acquired drug-induced acute kidney injuries[J]. Fundam Clin Pharmacol, 2022, 36(4):750-761. doi: 10.1111/fcp.12758. |
| [26] | Li Y, Ren K. The mechanism of contrast-induced acute kidney injury and its association with diabetes mellitus[J]. Contrast Media Mol Imaging, 2020, 2020:3295176. doi: 10.1155/2020/3295176. |
| [27] | Infante B, Conserva F, Pontrelli P, et al. Recent advances in molecular mechanisms of acute kidney injury in patients with diabetes mellitus[J]. Front Endocrinol(Lausanne), 2022, 13:903970. doi: 10.3389/fendo.2022.903970. |
| [28] | Bhattarai S, Pradhan SR, Bhattarai S. Low-dose atorvastatin therapy induced rhabdomyolysis in a liver cirrhosis patient-a case report[J]. Ann Med Surg (Lond), 2023, 85(10):5232-5234. doi: 10.1097/MS9.0000000000001231. |
| [29] | Wu NL, Hingorani S. Outcomes of kidney injury including dialysis and kidney transplantation in pediatric oncology and hematopoietic cell transplant patients[J]. Pediatr Nephrol, 2021, 36(9):2675-2686. doi: 10.1007/s00467-020-04842-7. |
| [30] | Huang YS, Wu CY, Chang TT, et al. Drug-induced liver injury associated with severe cutaneous adverse drug reactions: A nationwide study in Taiwan[J]. Liver Int, 2021, 41(11):2671-2680. doi: 10.1111/liv.14990. |
| [31] | Miao J, Herrmann SM. Immune checkpoint inhibitors and their interaction with proton pump inhibitors-related interstitial nephritis[J]. Clin Kidney J, 2023, 16(11):1834-1844. doi: 10.1093/ckj/sfad109. |
| [32] | Hakroush S, Kopp SB, Tampe D, et al. Variable expression of programmed cell death protein 1-ligand 1 in kidneys independent of immune checkpoint inhibition[J]. Front Immunol, 2020, 11:624547. doi: 10.3389/fimmu.2020.624547. |
| [33] | Yalçınkaya R, Öz FN, Kaman A, et al. Factors associated with acyclovir nephrotoxicity in children: Data from 472 pediatric patients from the last 10 years[J]. Eur J Pediatr, 2021, 180(8):2521-2527. doi: 10.1007/s00431-021-04093-0. |
| [34] | Vakilian A, Mohammadi S, Shokri F, et al. The renin-angiotensin system involvement in cisplatin-induced nephrotoxicity: An overview of physiological and pathological mechanisms-a systematic review[J]. Int J Nephrol, 2024, 2024:1511216. doi: 10.1155/2024/1511216. |
| [35] | Javed A, Mahmood T, Tiwari R, et al. Navigating nephropathy and nephrotoxicity: Understanding pathophysiology unveiling clinical manifestations, and exploring treatment approaches[J]. J Basic Clin Physiol Pharmacol, 2025, 36(2-3):69-93. doi: 10.1515/jbcpp-2024-0220. |
| [36] | Xie D, Hu G, Chen C, et al. Loss of sphingosine kinase 2 protects against cisplatin-induced kidney injury[J]. Am J Physiol Renal Physiol, 2022, 323(3):F322-F334. doi: 10.1152/ajprenal.00229.2021. |
| [37] | Desai RJ, Kazarov CL, Wong A, et al. Kidney damage and stress biomarkers for early identification of drug-induced kidney injury: A systematic review[J]. Drug Saf, 2022, 45(8):839-852. doi: 10.1007/s40264-022-01202-2. |
| [38] | Wang X, Mu J, Ma K, et al. Challenges of serum creatinine level in GFR assessment and drug dosing decisions in kidney injury[J]. Adv Pharm Bull, 2024, 14(4):745-758. doi: 10.34172/apb.42345. |
| [39] | Chen L, Smith J, Mikl J, et al. A multiplatform approach for the discovery of novel drug-induced kidney injury biomarkers[J]. Chem Res Toxicol, 2017, 30(10):1823-1834. doi: 10.1021/acs.chemrestox.7b00159. |
| [40] | Adedeji AO, Sonee M, Chen Y, et al. Evaluation of novel urinary biomarkers in beagle dogs with amphotericin b-induced kidney injury[J]. Int J Toxicol, 2023, 42(2):146-155. doi: 10.1177/10915818221142542. |
| [41] | Gu YZ, Vlasakova K, Darbes J, et al. Urine kidney safety biomarkers improve understanding of indirect intra-renal injury potential in dogs with a drug-induced prerenal azotemia[J]. Toxicology, 2020, 439:152462. doi: 10.1016/j.tox.2020.152462. |
| [42] | Sandelius Å, Basak J, Hölttä M, et al. Urinary kidney biomarker panel detects preclinical antisense oligonucleotide-induced tubular toxicity[J]. Toxicol Pathol, 2020, 48(8):981-993. doi: 10.1177/0192623320964391. |
| [43] | Kohl K, Herzog E, Dickneite G, et al. Evaluation of urinary biomarkers for early detection of acute kidney injury in a rat nephropathy model[J]. J Pharmacol Toxicol Methods, 2020, 105:106901. doi: 10.1016/j.vascn.2020.106901. |
| [44] | Chorley BN, Ellinger-Ziegelbauer H, Tackett M, et al. Urinary mirna biomarkers of drug-induced kidney injury and their site specificity within the nephron[J]. Toxicol Sci, 2021, 180(1):1-16. doi: 10.1093/toxsci/kfaa181. |
| [45] | Saito M, Horie S, Yasuhara H, et al. Metabolomic profiling of urine-derived extracellular vesicles from rat model of drug-induced acute kidney injury[J]. Biochem Biophys Res Commun, 2021, 546:103-110. doi: 10.1016/j.bbrc.2021.01.082. |
| [46] | Vivekaa A, Nellore J, Sunkar S. Zebrafish metabolomics: A comprehensive approach to understanding health and disease[J]. Funct Integr Genomics, 2025, 25(1):110. doi: 10.1007/s10142-025-01621-1. |
| [47] | Wang B, Wang Y, Wang J, et al. Multiparametric magnetic resonance investigations on acute and long-term kidney injury[J]. J Magn Reson Imaging, 2024, 59(1):43-57. doi: 10.1002/jmri.28784. |
| [48] | Virgincar RS, Wong AK, Barck KH, et al. Diffusion tensor MRI is sensitive to fibrotic injury in a mouse model of oxalate-induced chronic kidney disease[J]. Am J Physiol Renal Physiol, 2024, 327(2):F235-F244. doi: 10.1152/ajprenal.00099.2024. |
| [49] | Li A, Luo X, Li L, et al. Activatable multiplexed 19f magnetic resonance imaging visualizes reactive oxygen and nitrogen species in drug-induced acute kidney injury[J]. Anal Chem, 2021, 93(49):16552-16561. doi: 10.1021/acs.analchem.1c03744. |
| [50] | Chen Q, Yu J, Rush BM, et al. Ultrasound super-resolution imaging provides a noninvasive assessment of renal microvasculature changes during mouse acute kidney injury[J]. Kidney Int, 2020, 98(2):355-365. doi: 10.1016/j.kint.2020.02.011. |
| [51] | Kwon TJ, Jang E, Lee DS, et al. Development of a noninvasive kim-1-based live-imaging technique in the context of a drug-induced kidney-injury mouse model[J]. ACS Appl Bio Mater, 2021, 4(2):1508-1514. doi: 10.1021/acsabm.0c01392. |
| [52] | Tenebro CP, Marcial N, Salcepuedes JJ, et al. Visualization of renal rotenone accumulation after oral administration and in situ detection of kidney injury biomarkers via MALDI mass spectrometry imaging[J]. Front Mol Biosci, 2024, 11:1366278. doi: 10.3389/fmolb.2024.1366278. |
| [53] | Zhang G, Reeves WB. Spatial metabolomics in acute kidney injury[J]. Semin Nephrol, 2024, 44(6):151580. doi: 10.1016/j.semnephrol.2025.151580. |
| [54] | Rao M, Nassiri V, Srivastava S, et al. Artificial intelligence and machine learning models for predicting drug-induced kidney injury in small molecules[J]. Pharmaceuticals (Basel), 2024, 17(11):1550. doi: 10.3390/ph17111550. |
| [55] | Zhu W, Barreto EF, Li J, et al. Drug-drug interaction and acute kidney injury development: A correlation-based network analysis[J]. PLoS One, 2023, 18(1):e0279928. doi: 10.1371/journal.pone.0279928. |
| [56] | Yu P, Duan Z, Liu S, et al. Drug-induced nephrotoxicity assessment in 3D cellular models[J]. Micromachines (Basel), 2021, 13(1):3. doi: 10.3390/mi13010003. |
| [57] | Li X, Wang P, Zhu Y, et al. Interpretable machine learning model for predicting acute kidney injury in critically ill patients[J]. BMC Med Inform Decis Mak, 2024, 24(1):148. doi: 10.1186/s12911-024-02537-9. |
| [58] | Nagy M, Onder AM, Rosen D, et al. Predicting pediatric cardiac surgery-associated acute kidney injury using machine learning[J]. Pediatr Nephrol, 2024, 39(4):1263-1270. doi: 10.1007/s00467-023-06197-1. |
| [59] | Dong JF, Xue Q, Chen T, et al. Machine learning approach to predict acute kidney injury after liver surgery[J]. World J Clin Cases, 2021, 9(36):11255-11264. doi: 10.12998/wjcc.v9.i36.11255. |
| [60] | Liu W, Ji K, Tang Q, et al. Development and validation of interpretable machine learning models for predicting AKI risk in patients treated with PD-1/PD-L1: A retrospective study[J]. BMC Med Inform Decis Mak, 2025, 25(1):295. doi: 10.1186/s12911-025-03142-0. |
| [61] | Chen M, Zhang D. Machine learning-based prediction of post-induction hypotension: Identifying risk factors and enhancing anesthesia management[J]. BMC Med Inform Decis Mak, 2025, 25(1):96. doi: 10.1186/s12911-025-02930-y. |
| [62] | Qu C, Gao L, Yu XQ, et al. Machine learning models of acute kidney injury prediction in acute pancreatitis patients[J]. Gastroenterol Res Pract, 2020, 2020:3431290. doi: 10.1155/2020/3431290. |
| [63] | Hamed RG, Stephens G, Little M, et al. Data mapping challenges in reproducibility of machine learning for acute kidney injury prediction[J]. Stud Health Technol Inform, 2025, 328:220-224. doi: 10.3233/SHTI250706. |
| [1] | Zhang Hui, Zhang Wenbo, Liang Wenqi, Huo Yanhong. Idiopathic renal hypouricemia combined with repeated acute kidney injury: A case report and literature review [J]. Clinical Focus, 2025, 40(2): 168-171. |
| [2] | Pu Qian, Cheng Gang, Dao Jiecao, Qi Zizhao, Dou Lele, Zhao Junfang, Zhang Wenjun, Guo Caixia, Wang Yingying. Risk factors for constipation in patients with chronic kidney disease in Gansu province: a single-center study [J]. Clinical Focus, 2025, 40(1): 44-53. |
| [3] | Liu Yi, Zhao Haotian, Wang Xiaona, Liu Yuanlin, Li Li, Wang Zekai. Application value of right heart ultrasound combined with renal vascular doppler score in patients with end-stage renal disease during dialysis [J]. Clinical Focus, 2025, 40(1): 54-59. |
| [4] | Guo Xiaocui, Yu Xiaojuan, Shen Xia, Ye Shuiying, Zhou Dongchi, Lai Bihong. Effect of a multidisciplinary intervention on the quality of life in maintenance hemodialysis patients [J]. Clinical Focus, 2024, 39(9): 803-807. |
| [5] | . [J]. Clinical Focus, 2024, 39(9): 847-850. |
| [6] | . [J]. Clinical Focus, 2024, 39(2): 183-187. |
| [7] | Wang Lingling, Wu Jinlan, Wu Wei, Shen Shipeng, Chi Yanqing, Liu Maodong. A meta-analysis of the renal protective effects of vitamin D and its analogues in non dialysis patients with chronic kidney disease [J]. Clinical Focus, 2022, 37(12): 1081-1088. |
| [8] | Wang Pengrui, Chen Huaqian, Yang Tao, Zhao Li, Li Peng. The effect of serum intact parathyroid hormone level on the maturation of autogeneous arteriovenous fistula [J]. Clinical Focus, 2022, 37(12): 1094-1098. |
| [9] | Li Yingying, Li Ting, Zhang Ming, Fan Minghua, Xing Guangqun. Monitoring significance of CD4+ T lymphocyte count on evaluating frailty status of chronic renal failure in patients [J]. Clinical Focus, 2022, 37(3): 243-247. |
| [10] | Li Wenzhe, Shang Jinchun, Li Chunmei, Tian Fen, Li Jun, Cui Li, Xing Guangqun. Risk factors of cerebral hemorrhage in uremic patients on regular hemodialysis [J]. Clinical Focus, 2022, 37(1): 20-25. |
| [11] | Li Wenzhe, Shang Jinchun, Li Chunmei, Li Jun, Tian Fen, Cui Li, Chen Yipeng, Zhang Xiaofan, Xing Guangqun. Effect of sodium citrate anticoagulation in continuous renal replacement therapy on uremic patients with cerebral hemorrhage [J]. Clinical Focus, 2021, 36(5): 425-431. |
| [12] | Zhang Linli, Ma Xiaohong. Clinical features and risk factors of acute kidney injury after hip fracture in the elderly [J]. Clinical Focus, 2021, 36(5): 442-445. |
| [13] | Zhang Jinjin, Jin Ruixia, Sun Wei. High-flux hemodialysis in the frailty of elderly patients with end-stage renal disease [J]. Clinical Focus, 2021, 36(4): 328-331. |
| [14] | He Lianyi. Application effect of different dialysis frequencies in uremic patients [J]. Clinical Focus, 2015, 30(11): 1292-1.29513e+007. |
| [15] | Niu Kaiya;Yang Fan;Yang Xiaoyan;Ye Jun;Cheng Jiejing. Diagnostic value of urinary liver-type fatty acid binding proteins and urinary neutrophil gelatinase-associated lipocalin in severe sepsis patients with acute kidney injury [J]. Clinical Focus, 2015, 30(5): 536-539. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||